SCI
BIIB icon

Stableford Capital II’s Biogen BIIB Stock Holding History

Stableford Capital II’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.52M Sell
6,731
-181
-3% -$38.4K 0.53% 42
2026
Q2 		$1.49M Buy
6,912
+8
+0.1% +$1.53K 0.52% 43
2026
Q1 		$1.27M Sell
6,904
-10
-0.1% -$1.84K 0.47% 60
2025
Q4 		$1.22M Buy
+6,914
New +$1.13M 0.44% 65

Other funds holding BIIB

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
TF
Tompkins Financial Ithaca, New York $1.42B AUM 19.14% 1-Year Est. Return
BCM
Boltwood Capital Management Walnut Creek, California $443M AUM 17.72% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return

Stableford Capital II's BIIB Position: Q3 2026 in Review

Stableford Capital II reduced its Biogen (BIIB) stake by 2.6% in Q3 2026, selling an estimated $38.4K and leaving 6,731 shares worth $1.52M. The position accounts for 0.53% of the portfolio, ranked #42.

Stableford Capital II first reported a position in BIIB in Q4 2025 and has held it in 4 quarters since. 32 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Stableford Capital II held 6,731 shares of Biogen worth $1.52M as of Q3 2026.
  • Stableford Capital II sold 181 Biogen shares in Q3 2026, an estimated $38.4K.
  • Biogen made up 0.53% of Stableford Capital II's portfolio in Q3 2026, its #42 holding.
  • Stableford Capital II first reported a position in Biogen in Q4 2025 and has held it in 4 quarters since.
  • 32 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Stableford Capital II's 13F filing for Q3 2026, filed 9 Oct 2026.